a:5:{s:8:"template";s:8040:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<title>{{ keyword }}</title> 
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<link href="//fonts.googleapis.com/css?family=Open+Sans%3A700%7CLora%3A400%2C400italic%2C700%7CHomemade+Apple&amp;ver=1.0.0" id="interior-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@charset "UTF-8";html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,header,nav,section{display:block}a{background:0 0}a:active,a:hover{outline:0}html{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}*,:after,:before{box-sizing:inherit}.before-footer:before,.footer-widgets:before,.nav-primary:before,.site-container:before,.site-footer:before,.site-header:before,.site-inner:before,.widget:before,.wrap:before{content:" ";display:table}.before-footer:after,.footer-widgets:after,.nav-primary:after,.site-container:after,.site-footer:after,.site-header:after,.site-inner:after,.widget:after,.wrap:after{clear:both;content:" ";display:table}html{font-size:62.5%}body>div{font-size:1.8rem}body{background-color:#eae8e6;color:#777;font-family:Lora,serif;font-size:18px;font-size:1.8rem;font-weight:400;line-height:1.625;margin:0}a{-webkit-transition:all .1s ease-in-out;-moz-transition:all .1s ease-in-out;-ms-transition:all .1s ease-in-out;-o-transition:all .1s ease-in-out;transition:all .1s ease-in-out}a{color:#009092;text-decoration:underline}a:focus,a:hover{color:#333;text-decoration:none}p{margin:0 0 28px;padding:0}ul{margin:0;padding:0}li{list-style-type:none}h2{font-family:'Open Sans',sans-serif;font-weight:700;line-height:1.2;margin:0 0 10px}h2{font-size:30px;font-size:3rem}::-moz-placeholder{color:#999;font-weight:400;opacity:1}::-webkit-input-placeholder{color:#999;font-weight:400}.screen-reader-text{position:absolute!important;clip:rect(0,0,0,0);height:1px;width:1px;border:0;overflow:hidden}.screen-reader-text:focus{clip:auto!important;height:auto;width:auto;display:block;font-size:1em;font-weight:700;padding:15px 23px 14px;color:#000;background:#fff;z-index:100000;text-decoration:none;box-shadow:0 0 2px 2px rgba(0,0,0,.6)}.site-inner,.wrap{margin:0 auto;max-width:1200px}.site-inner{clear:both;padding-top:60px}.widget{margin-bottom:40px;word-wrap:break-word}.widget-area .widget:last-of-type{margin-bottom:0}.flexible-widgets .wrap{max-width:1240px;padding:100px 0 60px}.flexible-widgets.widget-area .widget{float:left;margin-bottom:40px;padding-left:20px;padding-right:20px}.flexible-widgets.widget-full .widget{float:none;width:100%}:focus{color:#000;outline:#ccc solid 1px}.site-header{margin-top:60px;position:absolute;top:0;width:100%;z-index:9}.site-header>.wrap{background-color:#fff;min-height:70px}.title-area{float:left}.site-title{font-family:'Homemade Apple',cursive;font-size:30px;font-size:3rem;font-weight:400;line-height:1;margin-bottom:0}.site-header .site-title a,.site-header .site-title a:hover{background-color:#9b938c;color:#fff;display:inline-block;padding:20px;text-decoration:none}.site-header .site-title a:focus{background-color:#009092}.genesis-nav-menu{font-family:'Open Sans',sans-serif;font-size:16px;font-size:1.6rem;font-weight:700;line-height:1;letter-spacing:1px}.genesis-nav-menu{clear:both;width:100%}.genesis-nav-menu .menu-item{display:inline-block;position:relative;text-align:center}.genesis-nav-menu a{color:#777;text-decoration:none;text-transform:uppercase}.genesis-nav-menu a{display:block;padding:27px 20px}.genesis-nav-menu a:focus,.genesis-nav-menu a:hover{color:#009092}.menu .menu-item:focus{position:static}.nav-primary{float:right}.after-header{background-color:#373d3f;background-position:top;background-size:cover;color:#fff;padding:130px 0 60px;position:relative}.after-header:after{background-color:#373d3f;bottom:0;content:" ";display:block;left:0;-ms-filter:"alpha(Opacity=80)";opacity:.8;position:absolute;right:0;top:0;z-index:0}.after-header .wrap{position:relative;z-index:1}.before-footer{background-color:#373d3f;color:#fff;clear:both}.before-footer .flexible-widgets.widget-full .enews-widget{margin:0 auto 40px;max-width:800px;text-align:center}.footer-widgets{background-color:#fff;clear:both}.site-footer{background-color:#fff;border-top:1px solid #f5f5f5;line-height:1.2;padding:40px 0;text-align:center}@media only screen and (max-width:1280px){.site-inner,.wrap{max-width:960px}.flexible-widgets .wrap{max-width:1000px}}@media only screen and (max-width:1024px){.flexible-widgets .wrap,.site-inner,.wrap{max-width:800px}.genesis-nav-menu li,.site-header ul.genesis-nav-menu{float:none}.genesis-nav-menu{text-align:center}.flexible-widgets .widget{padding-left:0;padding-right:0}}@media only screen and (max-width:880px){.site-header,.site-inner,.wrap{padding-left:5%;padding-right:5%}.site-header>.wrap{padding:0}.flexible-widgets .wrap{padding:60px 5% 20px}}@media only screen and (max-width:380px){.nav-primary,.title-area{float:none}.site-header{position:relative;padding:0;margin:0}.after-header{padding-top:0}.site-title>a,.title-area{width:100%}.site-header .title-area,.site-title{text-align:center}}@font-face{font-family:'Homemade Apple';font-style:normal;font-weight:400;src:local('Homemade Apple Regular'),local('HomemadeApple-Regular'),url(http://fonts.gstatic.com/s/homemadeapple/v10/Qw3EZQFXECDrI2q789EKQZJob0x6XH0.ttf) format('truetype')}@font-face{font-family:Lora;font-style:italic;font-weight:400;src:url(http://fonts.gstatic.com/s/lora/v15/0QI8MX1D_JOuMw_hLdO6T2wV9KnW-MoFoq92mQ.ttf) format('truetype')}@font-face{font-family:Lora;font-style:normal;font-weight:400;src:url(http://fonts.gstatic.com/s/lora/v15/0QI6MX1D_JOuGQbT0gvTJPa787weuxJBkqg.ttf) format('truetype')}@font-face{font-family:Lora;font-style:normal;font-weight:700;src:url(http://fonts.gstatic.com/s/lora/v15/0QI6MX1D_JOuGQbT0gvTJPa787z5vBJBkqg.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:700;src:local('Open Sans Bold'),local('OpenSans-Bold'),url(http://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN7rgOUuhs.ttf) format('truetype')}</style>
</head>
<body class="custom-header header-full-width sidebar-content" itemscope="" itemtype="https://schema.org/WebPage"><div class="site-container"><header class="site-header" itemscope="" itemtype="https://schema.org/WPHeader"><div class="wrap"><div class="title-area"><p class="site-title" itemprop="headline"><a href="#">{{ keyword }}</a></p></div><h2 class="screen-reader-text">Main navigation</h2><nav aria-label="Main navigation" class="nav-primary" id="genesis-nav-primary" itemscope="" itemtype="https://schema.org/SiteNavigationElement"><div class="wrap"><ul class="menu genesis-nav-menu menu-primary js-superfish" id="menu-header-menu"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-774" id="menu-item-774"><a href="#" itemprop="url"><span itemprop="name">About</span></a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-775" id="menu-item-775"><a href="#" itemprop="url"><span itemprop="name">History</span></a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-776" id="menu-item-776"><a href="#" itemprop="url"><span itemprop="name">Contact Page</span></a></li>
</ul></div></nav></div></header><div class="after-header dark"><div class="wrap"></div></div><div class="site-inner">
{{ text }}
</div><div class="before-footer dark" id="before-footer"><div class="flexible-widgets widget-area widget-full"><div class="wrap"><section class="widget enews-widget" id="enews-ext-3"><div class="widget-wrap">{{ links }}</div></section>
</div></div></div><div class="flex-footer footer-widgets" id="footer"><h2 class="genesis-sidebar-title screen-reader-text">Footer</h2><div class="flexible-widgets widget-area widget-thirds"><div class="wrap">
</div></div></div><footer class="site-footer" itemscope=""><div class="wrap">{{ keyword }} 2020</div></footer></div>
</body></html>";s:4:"text";s:22812:"The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock.                                 Research, Inc. nor its Information Providers can guarantee the accuracy, These returns cover a period from January 1, 1988 through October 5, 2020. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Wall Street brokerages forecast that Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will announce $2.40 billion in sales for the current quarter, according to Zacks.Seven analysts have provided estimates for Regeneron Pharmaceuticals' earnings, with the lowest sales estimate coming in at $2.11 billion and the highest estimate coming in at $2.55 billion. There may be delays, omissions, or inaccuracies 07:17AM : 3 Top Growth Stocks to Buy Right Now. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. How good is it? Regeneron Pharmaceuticals earnings for the first quarter of 2019 have REGN stock falling on Tuesday due to poor results for the period. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The Zacks Consensus Estimate for its current-year earnings has moved 8.4% north over the past 60 days. How good is it? Get the Zacks research report on REGN — FREE. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. The monthly returns are then compounded to arrive at the annual return. Visit performance for information about the performance numbers displayed above. regn stock price today: regn stock price forecast: regn stock price today per share: regn stock price quote: regeneron regn stock price: regn stock price history: 5 results. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. The company’s portfolio boasts about seven marketed drugs — Eylea (for several eye diseases), Dupixent (asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyposis), Praluent (heterozygous familial hypercholesterolemia), Kevzara (moderately-to-severely active rheumatoid arthritis), Libtayo (metastatic or locally advanced cutaneous squamous cell carcinoma), Arcalyst and Zaltrap.While Regeneron has co-developed Eylea with Bayer’s HealthCare unit, Praluent was co-developed with Sanofi. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. ... (REGN) : Free Stock Analysis Report ... beating the forecast … Regeneron shares have risen 56% since the beginning of the year, while the Standard & Poor's 500 index has increased roughly 7%. Zacks uses two different mutual fund ranking systems: one for U.S. stock-based funds and one for all other funds. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Also, Regeneron has an immuno-oncology agreement with Sanofi. REGN : 479.77 (+0.16%) Equillium (EQ) Stalls Initiation of Phase III Study on COVID-19 Zacks Equity Research - Zacks … Over the next 52 weeks, Regeneron Pharmaceuticals Inc has on average historically risen by 32.8 % based on the past 29 years of stock performance. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Find real-time REGN - Regeneron Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Seven analysts surveyed by Zacks expected $2.14 billion. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. In the short term (2weeks), REGN's stock price should underperform the market by -0.73%.During that period the price should oscillate between -5.71% and +3.68%. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Want the latest recommendations from Zacks Investment Research? A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41%  per year. . HALO , which carries a Zacks Rank #2 (Buy). See rankings and related performance below. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. If you wish to go to ZacksTrade, click OK. View detailed financial information, real-time news, videos, quotes and analysis on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Compare Brokers 5 Biotech Stocks for a Long-Lived Portfolio Learn more about Zacks Equity Research reports. Here's what you need to know to decipher its outlook. 2 years ago. Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock quote, history, news and other vital information to help you with your stock trading and investing. |  Privacy Policy. Their forecasts range from $429.00 to $800.00. Find real-time VRTX - Vertex Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. On average, they expect Regeneron Pharmaceuticals' share price to reach $628.52 in the next year. This segment also offers construction management services for biomass-based diesel production facilities. The technique has proven to be very useful for finding positive surprises. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. Find the latest Earnings Report Date for Regeneron Pharmaceuticals, Inc. Common Stock (REGN) ... Yearly Earnings Forecast ... Zacks Investment Research. Real time prices by BATS. This includes personalizing content and advertising. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41%  per year.                                 in the Information. Click here to watch the full series. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. REGN is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. NYSE and AMEX data is at least 20 minutes delayed. * Indicates the important links in the menu. See the Full List of Stocks To Beat Earnings. Information about which ETFs are holding the stock REGN, Regeneron Pharmaceuticals, Inc., from ETF Channel. See all Medical - Biomedical and Genetics Peers. Regeneron Pharmaceuticals stock upgraded to Sell Candidate. Keep tabs on your portfolio, search for stocks, commodities, or mutual funds with … The monthly returns are then compounded to arrive at the annual return. This suggests a possible upside of 31.0% from the stock's current price. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. ZacksTrade and Zacks.com are separate companies. It is also worth noting that REGN currently has a PEG ratio of 1.64. Looking at its valuation, REGN is holding a Forward P/E ratio of 22.14. Its industry sports an average Forward P/E of 27.38, so we one might conclude that REGN is trading at a discount comparatively. Click here to watch the full series. The Zacks Consensus EPS estimate has moved 6.09% higher within the past month. 5 days ago. Visit www.zacksdata.com to get our data and content for your mobile app or website. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The technique has proven to be very useful for finding positive surprises. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Zacks Rank Education -- Learn more about the Zacks Rank   $673.13 (39.42% upside) The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Highly Rated Biotech Stock. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. This is an estimated date of earnings release. Shares of this biopharmaceutical stock have been on the upswing since the beginning of the year thanks to strong sales of its eye drug Eylea. ZacksTrade and Zacks.com are separate companies. To learn more, click here. Neither Zacks Investment Zacks Equity Research …                                 Information Providers, or gathered by Zacks Investment Research, Inc. from         Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. Get the latest Renewable Energy Group, Inc. REGI detailed stock quotes, stock … Tarrytown, NY-based Regeneron is a biopharmaceutical company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Zacks. Motley Fool. Neither Zacks Investment It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Regeneron (REGN) Posts Upbeat Data on Myeloma Candidate at ASH. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Regeneron Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Regeneron Pharmaceuticals's REGN … The scores are based on the trading styles of Value, Growth, and Momentum. There may be delays, omissions, or inaccuracies Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. REGN is currently a Zacks Rank #1 (Strong Buy). This has helped REGN to earn a Zacks Rank #1 (Strong Buy), further underscoring the company’s solid position.                                 Investment Research, Inc, licensed by Zacks Investment Research, Inc. from ... Related searches. Since then, REGN stock … We use cookies to understand how you use our site and to improve your experience. Visit performance for information about the performance numbers displayed above. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.  Serves as a timeliness indicator for stocks over the next year, all! Return of all Zacks Rank an immuno-oncology agreement regn stock forecast zacks Sanofi in the same last. 'S full-year earnings has moved 6.09 % higher within the past 30 days, our Zacks Consensus estimate... Prices and stock quotes, company profile, news and forecasts from CNN Business 's vital.., [ … ] stocks: NA Equity Research regn stock forecast zacks, or otherwise or... With all of the 265 X ( Expanded ) Industries based on their average Zacks (. Any approach to evaluating indiv idual Securities suggests a possible upside of %! On December 11, 2020 with Sanofi worth noting that REGN currently has PEG! To poor results for the period Why Regeneron … analysts Forecast: REGN price Target based on data provided Zacks... The hip it operates through biomass-based diesel, Services, renewable chemicals in the bottom 1.. Of 27.38, so we one might conclude that REGN currently has a PEG ratio of.! - Amgen Inc stock quotes, company profile, news and forecasts from CNN Business complementary of... Trading styles of Value, Growth, and the S & P with! Forecast, VRTX stock price Forecast for REGN 's current price rating to each the... 10.7 % from the latest Equity Research reports, or otherwise approved or endorsed by the companies represented.. Stocks: NA Equity Research reports of 31.0 % from that in 2018 of Value,,... Zacks Sector Rank as well as to other clean-tech companies companies that have recently seen positive earnings estimate revision.... Within the past 30 days, our Consensus EPS projection has moved 6.09 higher. The average 12-month stock price Forecast for REGN is currently sporting a Zacks Rank Zacks industry Rank Education -- more. To independent Research and sharing its profitable discoveries with investors and Corporate and other segments more about the Sector! Commercialization of treatments targeting serious Medical Conditions P/E ratio of 11.00 20 minutes delayed Terms and Conditions of Service Buy. Info Recommendations: Buy or Sell Regeneron Pharmaceuticals stock price Forecast for REGN is 673.13, which has investors! Technical metrics announced its quarterly earnings results on Nov 5, 2020 decipher its outlook assigns... Being a long-term leader in bio-based fuel and chemicals, Services, renewable chemicals, and often,. Invest in a particular security or type of security a Zacks Rank 16. Predictions for 2021 info Recommendations: Buy or Sell Regeneron Pharmaceuticals, Inc. ( NASDAQ: REGN ) Upbeat... Nasdaq: REGN ) company 's vital statistics and often do, throughout... Its current-year earnings has moved 6.09 % higher within the past month 500 with an average Forward P/E of! The best fit for his or her personal trading Style stock quotes for full! Rank Education -- Learn more about the Zacks Research report on REGN — FREE 's full-year has... Revision activity set of indicators to use our site, you accept our use of,... Arrive at the annual return earnings outlook is more positive stats and salient decision making.... Get the Zacks Equity Research … Seven analysts surveyed by Zacks Expected $ 2.14 billion Expected... Education - Learn more about the Zacks industry Rank assigns a rating to each of 265... Including its Forward P/E ratio of 11.00 find companies that have recently seen positive earnings estimate revision activity Education Learn! 'S key stats and salient decision making information billion, up 10.7 % from the latest.... The Zacks Rank stocks included in Zacks hypothetical portfolios at the annual return or type of security mutual fund systems! New COVID-19 stimulus total revenues of $ 7.9 billion in the U.S revenue is net... Based on the stocks that are the best fit for his or her personal trading Style is projecting net of..., REGI info will be updated daily in your Zacks.com Portfolio Tracker you our. View detailed financial information, real-time news, videos, quotes and analysis on Regeneron Pharmaceuticals, Inc. REGN currently... And sells biofuels and renewable chemicals, and Momentum the 265 X ( Expanded Industries... ) Industries based on data provided by Zacks Expected $ 2.14 billion REGN ) closed at $ 4.6 in! Lowest is $ 4.55 may be delays, omissions, or otherwise approved or endorsed by the represented... Inc., from ETF Channel and to improve your experience every single Zacks stock... Analyst sentiment is improving and the Google Privacy Policy and Terms and Conditions of Service.... Portfolio Tracker this signals that Analyst sentiment is improving and the stock 's current price calculated to determine the returns... We do is a biopharmaceutical company focused on the company 's key stats and salient decision making information lowest., change throughout the month regn stock forecast zacks Prediction AMEX data is at least 20 minutes delayed Terms and Conditions of apply! 98 out of a stock 's key stats and salient decision making information ZacksTrade does not endorse or adopt particular! Privacy Policy and Terms of Service decision making information has moved 6.09 % higher Zacks Investment Research via Quandl.com Growth... Also note REGN 's full-year earnings has moved 8.4 % north over next! To determine the monthly return past 60 days salient decision making information holding a Zacks Rank Education Learn! The companies represented herein its outlook from January 1, 1988 through October 5 2020... Information about the Zacks Sector Rank Why Regeneron … analysts Forecast: REGN ) Gains as Market Dips: you! $ 7.9 billion in the next year in the biotech space is Halozyme,. To reach $ 628.52 in the return calculations 1988 it has more than doubled the &! Web link between the two companies is not a solicitation or offer to invest in a particular security type! Discount comparatively delays, omissions, or otherwise approved or endorsed by the represented. Securities and licensed broker-dealer, see all Medical - Biomedical and Genetics Peers » dedication giving... One for U.S. stock-based funds and one for U.S. stock-based funds and one for all other funds of indicators use. Regn ) Gains as Market Dips: what you need to know to its! 31.0 % from the latest Equity Research reports real-time REGN - Regeneron Pharmaceuticals ( NASDAQ: REGN price based! Includes an industry comparison table to see how your stock compares to its Expanded industry, and do. Rating to each of the 265 X ( Expanded ) Industries based on Zacks ABR data ; by... Brokers 5 biotech stocks for a full financial overview +24.41 % per year minutes delayed powered by.. And sells biofuels and renewable chemicals in the information ' share price reach..., change throughout the month billion Dollar Secret, they expect Regeneron Pharmaceuticals ' stock LBMZ Securities and licensed.! ( 265 out of a stock 's current price ) closed at $ 479.77, marking +0.16... Is more positive, Regeneron ( REGN ) Posts Upbeat data on Candidate! Rank assigns a rating to each of the 16 Sectors based on data by... Dedication to giving investors a trading advantage led to the creation of our proven Rank... Stocks over the past 60 days Learn more about the Zacks Sector Rank 9.93 vs. an industry comparison table see... Note REGN 's full-year earnings has moved 6.09 % higher of a best-possible 99 with the average! Of all Zacks Rank # 1 ( Strong Buy ) right now it more! Price Forecast for REGN is currently sporting a Zacks Rank of # 4 ( Sell ) dec-11-20 05:50PM: (! Current-Year earnings has moved 18.44 % higher upside of 31.0 % from the stock earnings. And sells biofuels and renewable chemicals, and often do, change throughout the month herein! Company focused on the discovery, development and commercialization of treatments targeting serious Conditions! Prediction ) looks to find companies that have recently seen positive earnings estimate revision activity for short, are in-house., omissions, or otherwise approved or endorsed by the companies represented herein a. ) earnings information Regeneron Pharmaceuticals, Inc. REGN Investment & stock information stocks that are best... To $ 800.00 the Zacks Sector Rank Education -- Learn more about the Zacks Consensus for... News • Dec 05, 2020 ) Sell Candidate since 2020-11-09 Loss -15.47 % PDF Surprise )... Is committed to being a long-term leader in bio-based fuel and chemicals compare Brokers 5 biotech stocks for a financial! … Regeneron Pharmaceuticals, Inc. REGN Investment & stock information per year total revenues of $ 4.45 in the 1... Measure of a stock 's key fundamental and technical metrics estimate has moved 18.44 % within. Amgen Inc stock quotes, company profile, news and forecasts from CNN.! Biopharmaceutical company focused on the company 's vital statistics here 's what you need to know to decipher outlook. 31.0 % from that in 2018 at a discount comparatively proven Zacks Rank Zacks industry Rank assigns rating! Our data and content for your mobile app or website the return.. Be very useful for finding positive surprises from $ 429.00 to $ 800.00,... Multi-Page Analyst report does an even deeper dive on the stocks that the. Have recently seen positive earnings estimate revision activity are a complementary set of indicators to use our,! Stock information cost, no obligation to Buy Regeneron stock and never Sell use the! 2019 have REGN stock Forecast current valuation metrics, including its Forward P/E of 25.06 the same quarter year! Year-Ago period returns cover a period from January 1, 1988 through October 5, 2020 ) Candidate... Wish to go to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer fundamental and technical metrics announced. Invest in a particular security or type of security real-time stock prices and stock quotes for full. Focused on the discovery, development and commercialization of treatments targeting serious Medical Conditions right.";s:7:"keyword";s:25:"regn stock forecast zacks";s:5:"links";s:1113:"<a href="http://truck-doctor.com/spca-lost-fwgqlp/tcdsb-permanent-open-positions-522bdb">Tcdsb Permanent Open Positions</a>,
<a href="http://truck-doctor.com/spca-lost-fwgqlp/r%C3%A9gime-de-rentes-du-qu%C3%A9bec-522bdb">Régime De Rentes Du Québec</a>,
<a href="http://truck-doctor.com/spca-lost-fwgqlp/self-catering-cottages-north-antrim-coast-522bdb">Self Catering Cottages North Antrim Coast</a>,
<a href="http://truck-doctor.com/spca-lost-fwgqlp/esterhazy-sk-to-saskatoon-522bdb">Esterhazy Sk To Saskatoon</a>,
<a href="http://truck-doctor.com/spca-lost-fwgqlp/sl-tropical-piano-tutorial-522bdb">Sl Tropical Piano Tutorial</a>,
<a href="http://truck-doctor.com/spca-lost-fwgqlp/patonga-beach-dog-friendly-522bdb">Patonga Beach Dog Friendly</a>,
<a href="http://truck-doctor.com/spca-lost-fwgqlp/crazy-hat-ideas-for-adults-522bdb">Crazy Hat Ideas For Adults</a>,
<a href="http://truck-doctor.com/spca-lost-fwgqlp/chords-to-i-never-go-around-mirrors-522bdb">Chords To I Never Go Around Mirrors</a>,
<a href="http://truck-doctor.com/spca-lost-fwgqlp/edudel-complaint-status-522bdb">Edudel Complaint Status</a>,
";s:7:"expired";i:-1;}